Zarxio (filgrastim-sndz)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   March 2016 WARNINGS AND PRECAUTIONS Glomerulonephritis Glomerulonephritis has occurred in patients receiving filgrastim...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts